膣ペッサリーの世界市場：洞察、競合情勢、市場予測：2030年

世界の膣ペッサリーの市場規模は、2023年に2億9,534万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に9.76％のCAGRで拡大し、2030年には5億1,478万米ドルに達すると予測されています。骨盤臓器脱とストレス性尿失禁の有病率の上昇と、骨盤臓器脱になりやすい高齢者人口の増加が、膣ペッサリー市場を促進します。さらに、世界中で非侵襲的な治療オプションの需要が増加していることも市場を強化し、2024年から2030年の予測期間中に膣ペッサリー市場全体の成長に貢献すると予測されます。

膣ペッサリー市場は、様々な理由により製品需要が拡大しています。骨盤臓器脱やストレス性尿失禁の有病率の上昇や、骨盤臓器脱や尿失禁を起こしやすい高齢者人口の増加が、世界中で膣ペッサリー市場を牽引すると予想されています。

例えば、全米コンチネンス協会2019によると、アメリカでは最大4,000万人の女性が人生のある時点で膀胱漏れの問題を経験しています。2019年の同調査によると、新米母親のほぼ半数が正常分娩後に、約6人に1人が帝王切開後に失禁を経験しています。さらに、2019年に米国家庭医学会が言及した研究によると、尿失禁（UI）は一般的な問題であり、米国の成人女性の有病率は51％です。

さらに、2022年にオーストラリアのコンチネンス財団が提供したデータによると、同年には500万人以上のオーストラリア人（15歳以上の4人に1人）が膀胱または腸のコントロール障害を経験しており、尿失禁患者の80％は女性です。世界の他の地域でも同様の傾向が見られると予測されます。

当レポートでは、世界の膣ペッサリー市場について調査し、市場の概要とともに、タイプ別、適応症別、最終用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 膣ペッサリー市場レポートイントロダクション

第2章 膣ペッサリー市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 膣ペッサリー市場の主な要因分析

• 膣ペッサリー市場の促進要因
• 膣ペッサリー市場の抑制要因と課題
• 膣ペッサリー市場の機会

第5章 膣ペッサリー市場におけるポーターのファイブフォース分析

第6章 膣ペッサリー市場に対するCOVID-19の影響分析

第7章 膣ペッサリーの市場概要

• タイプ別
• 適応症別
• 最終用途別
• 地域別

第8章 膣ペッサリー市場の世界企業シェア分析-主要3～5社

第9章 膣ペッサリー市場の企業と製品のプロファイル

• CooperSurgical
• MEDGYN PRODUCTS, INC.
• Panpac Medical Corp.
• Integra LifeSciences
• Bliss GVS Pharma
• Bioteque America Inc.
• Personal Medical Corporation
• Arabin GmbH & Co. KG
• medesign I.C. GmbH
• IndoSurgicals Private Limited.
• Desco Medical India
• Narang Medical Limited.
• Bray Group Limited.
• Digitimer Ltd
• Thomas Medical.

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Vaginal pessary Market in Global (2021-2030)
• Table 4: Vaginal pessary Market in Global by Type (2021-2030)
• Table 5: Vaginal pessary Market in Global by Indication (2021-2030)
• Table 6: Vaginal pessary Market in Global by End User (2021-2030)
• Table 7: Vaginal pessary Market in Global by Geography (2021-2030)
• Table 8: Vaginal pessary Market in North America (2021-2030)
• Table 9: Vaginal pessary Market in North America by Country (2021-2030)
• Table 10: Vaginal pessary Market in the US (2021-2030)
• Table 11: Vaginal pessary Market in Canada (2021-2030)
• Table 12: Vaginal pessary Market in Mexico (2021-2030)
• Table 13: Vaginal pessary Market in Europe (2021-2030)
• Table 14: Vaginal pessary Market in Europe by Country (2021-2030)
• Table 15: Vaginal pessary Market in France (2021-2030)
• Table 16: Vaginal pessary Market in Germany (2021-2030)
• Table 17: Vaginal pessary Market in the United Kingdom (2021-2030)
• Table 18: Vaginal pessary Market in Italy (2021-2030)
• Table 19: Vaginal pessary Market in Spain (2021-2030)
• Table 20: Vaginal pessary Market in Russia (2021-2030)
• Table 21: Vaginal pessary Market in Rest of Europe (2021-2030)
• Table 22: Vaginal pessary Market in APAC (2021-2030)
• Table 23: Vaginal pessary Market in APAC by Country (2021-2030)
• Table 24: Vaginal pessary Market in China (2021-2030)
• Table 25: Vaginal pessary Market in Japan (2021-2030)
• Table 26: Vaginal pessary Market in India (2021-2030)
• Table 27: Vaginal pessary Market in Australia (2021-2030)
• Table 28: Vaginal pessary Market in South Korea (2021-2030)
• Table 29: Vaginal pessary Market in Rest of APAC (2021-2030)
• Table 30: Vaginal pessary Market in Rest of World (2021-2030)
• Table 31: Vaginal pessary Market in RoW by Region (2021-2030)
• Table 32: Vaginal pessary Market in Middle East (2021-2030)
• Table 33: Vaginal pessary Market in Africa (2021-2030)
• Table 34: Vaginal pessary Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Vaginal pessary Market in Global (2021-2030)
• Figure 4: Vaginal pessary Market in Global by Type (2021-2030)
• Figure 5: Vaginal pessary Market in Global by Indication (2021-2030)
• Figure 6: Vaginal pessary Market in Global by End User (2021-2030)
• Figure 7: Vaginal pessary Market in Global by Geography (2021-2030)
• Figure 8: Vaginal pessary Market in North America (2021-2030)
• Figure 9: Vaginal pessary Market in North America by Country (2021-2030)
• Figure 10: Vaginal pessary Market in the US (2021-2030)
• Figure 11: Vaginal pessary Market in Canada (2021-2030)
• Figure 12: Vaginal pessary Market in Mexico (2021-2030)
• Figure 13: Vaginal pessary Market in Europe (2021-2030)
• Figure 14: Vaginal pessary Market in Europe by Country (2021-2030)
• Figure 15: Vaginal pessary Market in France (2021-2030)
• Figure 16: Vaginal pessary Market in Germany (2021-2030)
• Figure 17: Vaginal pessary Market in the United Kingdom (2021-2030)
• Figure 18: Vaginal pessary Market in Italy (2021-2030)
• Figure 19: Vaginal pessary Market in Spain (2021-2030)
• Figure 20: Vaginal pessary Market in Russia (2021-2030)
• Figure 21: Vaginal pessary Market in Rest of Europe (2021-2030)
• Figure 22: Vaginal pessary Market in APAC (2021-2030)
• Figure 23: Vaginal pessary Market in APAC by Country (2021-2030)
• Figure 24: Vaginal pessary Market in China (2021-2030)
• Figure 25: Vaginal pessary Market in Japan (2021-2030)
• Figure 26: Vaginal pessary Market in India (2021-2030)
• Figure 27: Vaginal pessary Market in Australia (2021-2030)
• Figure 28: Vaginal pessary Market in South Korea (2021-2030)
• Figure 29: Vaginal pessary Market in Rest of APAC (2021-2030)
• Figure 30: Vaginal pessary Market in Rest of World (2021-2030)
• Figure 31: Vaginal pessary Market in RoW by Region (2021-2030)
• Figure 32: Vaginal pessary Market in Middle East (2021-2030)
• Figure 33: Vaginal pessary Market in Africa (2021-2030)
• Figure 34: Vaginal pessary Market in South America (2021-2030)
• Figure 35: Market Drivers
• Figure 36: Market Barriers
• Figure 37: Marker Opportunities
• Figure 38: PORTER'S Five Force Analysis

Vaginal Pessary Market By Type (Gellhorn, Ring, Donut, And Others), By Indication (Pelvic Organ Prolapse And Stress Urinary Incontinence), By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of pelvic organ prolapse and stress urine incontinence and the rising number of geriatric population that are prone to pelvic organ prolapse

Global vaginal pessary market was valued at USD 295.34 million in 2023, growing at a CAGR of 9.76% during the forecast period from 2024 to 2030 to reach USD 514.78 million by 2030. The increasing prevalence of pelvic organ prolapse and stress urine incontinence and the rising number of geriatric population that are prone to pelvic organ prolapse will propel the market of the vaginal pessary. Moreover, the increasing demand of noninvasive treatment options across the world are also anticipated to bolster the market, thereby contributing to the growth of the overall vaginal pessary market during the forecast period from 2024-2030.

Vaginal Pessary Market Dynamics:

The vaginal pessary market is witnessing a growth in product demand owing to various reasons. The increasing prevalence of pelvic organ prolapse and stress urine incontinence and the rising number of geriatric population that are prone to pelvic organ prolapse and urinary incontinence across the world is expected to drive the vaginal pessary market.

For instance, For instance, according to the National Association for Continence 2019, up to 40 million women in America have experienced bladder leakage issues at some point in their lives. As per the same study in 2019, almost half of the new mothers experience incontinence following a normal delivery and about one in six following a cesarean section. Additionally, as per the study mentioned by the American Academy of Family Physicians in 2019, urinary incontinence (UI) is a common issue, with a prevalence of 51% among adult women in the United States.

Moreover, as per the data provided by the Continence Foundation of Australia in 2022, over 5 million Australians - 1 in 4 people aged 15 years or over - experienced bladder or bowel control problems in the same year, and 80% of people with urinary incontinence are women. Similar trends are likely to be observed in other regions of the world.

Also, it is observed that stress urinary incontinence is more common among women between the age of 41 and 55 and above. Thus, a rise in women aging population could also increase the risk of developing stress urinary incontinence, thereby bolstering the market. For instance, as per the World Population Ageing 2020 highlights published by the United Nations, women aged 65 years or over accounted for 55% of the total global population in 2020. Thus, the burgeoning cases of the diseases will contribute to the growth of the global vaginal pessary market in the upcoming years.

One of the prominent drivers of the vaginal pessary market is a surge in the aging population that is prone to urinary incontinence and weakening of the pelvic floor. For instance, according to the UN Report, World Population Ageing 2020 Highlights, globally, there were about 727 million people aged 65 years and above in 2020. Also, as per the same source, over the next three decades, the number of older people worldwide is projected to be more than double, reaching approximately 1.5 billion by 2050. Moreover, according to the United States Census Bureau 2022, more than 54 million adults above the age of 65 were living in the United States in the year 2023, accounting for about 16.5% of the United States population. As per the same source, the number of older adults living in the United States is large and growing; the total number of adults aged 65 years and older is projected to rise to an estimated number of 85.7 million by 2050, which accounts for about 20% of the overall population in the United States.

Furthermore, the number of people aged 65 years and over is expected to increase by 1.6% throughout 2022-2022 to a total of 12.7 million, accounting for about 18.9% of the total United Kingdom (UK) population. Moreover, according to the European Union 2020, in 2020, 28.7% of the population are 65 years and above in Japan. As per the same source, by 2036, people aged 65 and over will represent one-third of Japan's population.

Thus, the surge in the aging population will lead to the development of urinary incontinence, thereby leading to the weakening of the pelvic floor requiring treatment using vaginal pessaries are further contributing to the growth of the vaginal pessaries market during the forecast period from 2024 to 2030.

Thus, all the above mentioned factors will drive the market for vaginal pessary during the forecast period from 2024-2030.

However, the frequent replacement of the pessary which requires necessary visit to the doctor several times to have one fitted and some women cannot use it because of some other concerns such as women with lichen sclerosis cannot use pessaries to address their prolapse symptoms, women who had a hysterectomy and have prolapse have trouble keeping the pessary inside the body. These factors may hamper the market growth of the vaginal pessary.

The ongoing COVID-19 pandemic has slightly impacted the market for vaginal pessary. At the onset of the disease, there was a significant shortage, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Hospital admissions for patients suffering from urological and other chronic disorders were not a priority in comparison to the patients suffering from coronavirus. Production of some medical devices was shut down. Furthermore, surgeries were temporarily stopped during the pandemic. To reduce the COVID-19 transmission risk, the physician have either postponed or canceled the semi-urgent and elective cases. However, with masses being vaccinated and with the return of resources and raw material, the vaginal pessary market has picked momentum.

Vaginal Pessary Market Segment Analysis:

Vaginal pessary Market by Type (Gellhorn, Ring, Donut, and Others), by Indication (Pelvic Organ Prolapse and Stress Urinary Incontinence), by End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application type segment of the vaginal pessary market, the stress urinary incontinence is estimated to hold a significant share in the vaginal pessary market in the year 2023. This can be ascribed to the various application that is associated with this application.

For instance, according to the data published by the National Health Service (NHS), in 2022, between 3 and 6 million people in the UK might have some degree of urinary incontinence, with stress urinary incontinence being the most common of all types.

Moreover, the rising aging population in the United Kingdom is one of the risk factors for the developing stress urinary incontinence in the population. According to the United Nations Department of Economic and Social Affairs, Population Division, World Population Ageing 2019 Highlights, the prevalence of the population aged >=65 years in the United Kingdom in 2019 was 12,499,000. As per their estimates, the prevalence is projected to rise to 15,166,000 by 2030. Thus, the increasing prevalence of stress urinary incontinence will propel the market demand of vaginal pessary during the forecast period.

North America is expected to dominate the overall Vaginal Pessary Market:

Among all the regions, North America is expected to account for the significant share in the global vaginal pessary market.

Increasing prevalence of pelvic organ prolapse and stress urine incontinence and rising number of geriatric population that are prone to pelvic organ prolapse is expected to increase the demand for vaginal pessary in North America, leading to a rise in the overall vaginal pessary market growth. Furthermore, the increasing demand of noninvasive treatment options is also expected to drive the market growth.

For instance, as per the latest data available from Urology Care Foundation 2022, around one in three women suffer from stress urinary incontinence at some point in their lives, and it increases with age. Thus, the burgeoning cases of the diseases will contribute to the growth of the vaginal pessaries market in the region as the demand will increase.

Moreover, the rise in the population in the region who are susceptible to developing stress urinary incontinence is likely to increase the demand for these devices. The people at risk mainly include aging women, the population with weak pelvic muscles, obese people, and others. For instance, various studies have reported that obesity and overweight are directly associated with urinary incontinence and are independent risk factors for stress-related and mixed urinary incontinence. This is because obesity increases intra-abdominal pressures, which adversely stresses the pelvic floor and can contribute to urinary stress incontinence.

As per the Centers for Disease Control and Prevention (CDC) 2022, in the year 2020, the prevalence of obesity in the United States was 41.9%. As per the same source, it was calculated that through 2017 to March 2020, US obesity prevalence increased from 30.5% to 41.9%. During the same time, the prevalence of severe obesity increased from 4.7% to 9.2%. The increasing prevalence of obesity in the region may increase the risk of developing urinary incontinence which may further lead to the increased demand of the vaginal pessary. Therefore, increasing the overall market growth of the vaginal pessary in the North America in the year 2023 - 2028.

Thus, all the above-mentioned factors are anticipated to propel the North America vaginal pessary market growth.

Vaginal Pessary Market Key Players:

Some of the key market players operating in the vaginal pessary market include CooperSurgical, MEDGYN PRODUCTS, INC., Panpac Medical Corp., Integra LifeSciences, Bliss GVS Pharma, Bioteque America Inc., Personal Medical Corporation, Arabin GmbH & Co. KG, medesign I.C. GmbH, IndoSurgicals Private Limited., Desco Medical India, Narang Medical Limited., Bray Group Limited., Digitimer Ltd, Thomas Medical., among others.

Recent Developmental Activities in the Vaginal Pessary Market:

In March 2022, Indegene, a global enterprise healthtech solutions company and ConTIPI Medical Ltd, an innovator in the field of providing non-surgical and disposable solutions for women with various pelvic floor disfunctions, announced a partnership to bring a new device to the market to help women suffering from Pelvic Organ Prolapse (POP).

In November 2019, ConTIPI Medical, announced the development of a cutting edge non-surgical and disposable vaginal solutions for women with various Pelvic Floor Disorders. Within the vagina the devices open and provide support to predefined specific sites along vaginal walls. By the end of use, devices are removed by a pull of a string, which causes them to considerably diminish in size for disposal.

Key Takeaways from the Vaginal Pessary Market Report Study

• Market size analysis for current vaginal pessary market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vaginal pessary market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global vaginal pessary market.
• Various opportunities available for the other competitor in the vaginal pessary market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current vaginal pessary market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for vaginal pessary market growth in the coming future?

Target Audience who can be benefited from this Vaginal Pessary Market Report Study

• Vaginal pessary products providers
• Research organizations and consulting companies
• Vaginal pessary-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in vaginal pessary
• Various End-users who want to know more about the vaginal pessary market and latest technological developments in the vaginal pessary market.

Frequently Asked Questions for Vaginal Pessary Market:

1. What are vaginal pessary?

A vaginal pessary, is a medical device which is inserted into the vagina to support pelvic organs such as uterus, vagina, bladder, and rectum. The pessary are implanted to support sagging organs that have prolapsed or stopped urine flow.

2. What is the market for Global Vaginal pessary?

Global vaginal pessary market was valued at USD 295.34 million in 2023, growing at a CAGR of 9.76% during the forecast period from 2024 to 2030 to reach USD 514.78 million by 2030.

3. What are the drivers for the Global Vaginal pessary Market?

The vaginal pessary market is witnessing a positive market growth owing to the increasing prevalence of pelvic organ prolapse and stress urine incontinence and the rising number of geriatric population that are prone to pelvic organ prolapse. Additionally, the increasing demand of non-invasive treatment options across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Vaginal pessary Market?

Some of the key market players operating in the vaginal pessary market include Cooper Surgical, MEDGYN PRODUCTS, INC., Panpac Medical Corp., Integra LifeSciences, Bliss GVS Pharma, Bioteque America Inc., Personal Medical Corporation, Arabin GmbH & Co. KG, medesign I.C. GmbH, IndoSurgicals Private Limited., Desco Medical India, Narang Medical Limited., Bray Group Limited., Digitimer Ltd, Thomas Medical., others.

5. Which region has the highest share in vaginal pessary Market?

North America is expected to hold the highest share in the revenue in the vaginal pessary market during the forecast period. Increasing prevalence of pelvic organ prolapse and stress urine incontinence and rising number of geriatric population that are prone to pelvic organ prolapse will increase the demand for vaginal pessary in North America.

Table of Contents

1.Vaginal pessary Market Report Introduction

2.Vaginal pessary Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Vaginal pessary Market Key Factors Analysis

• 4.1. Vaginal pessary Market Drivers
  • 4.1.1. Increasing prevalence of pelvic organ prolapse and stress urine incontinence
  • 4.1.2. Rising number of geriatric population that are prone to pelvic organ prolapse
  • 4.1.3. Increasing demand of noninvasive treatment options
• 4.2. Vaginal pessary Market Restraints and Challenges
  • 4.2.1. Should be replaced frequently
  • 4.2.2. Not suitable for all women
• 4.3. Vaginal pessary Market Opportunities
  • 4.3.1. Utilization of 3D printing technology
  • 4.3.2. Development of customized implants and painless implantation procedure

5. Vaginal pessary Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vaginal pessary Market

7. Vaginal pessary Market Layout

• 7.1. By Type
  • 7.1.1. Gellhorn
  • 7.1.2. Ring
  • 7.1.3. Donut
  • 7.1.4. Others
• 7.2. By Indication
  • 7.2.1. Pelvic Organ Prolapse
  • 7.2.2. Stress Urinary Incontinence
• 7.3. By End-use
  • 7.3.1. Hospitals & Clinics
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States
    • 7.4.1.2. Canada
    • 7.4.1.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. France
    • 7.4.2.2. Germany
    • 7.4.2.3. United Kingdom
    • 7.4.2.4. Italy
    • 7.4.2.5. Spain
    • 7.4.2.6. Russia
    • 7.4.2.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China
    • 7.4.3.2. Japan
    • 7.4.3.3. India
    • 7.4.3.4. Australia
    • 7.4.3.5. South Korea
    • 7.4.3.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East
    • 7.4.4.2. Africa
    • 7.4.4.3. South America

8. Vaginal pessary Market Global Company Share Analysis - Key 3-5 Companies

9. Vaginal pessary Market Company and Product Profiles

• 9.1. CooperSurgical
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. MEDGYN PRODUCTS, INC.
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Panpac Medical Corp.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Integra LifeSciences
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Bliss GVS Pharma
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Bioteque America Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Personal Medical Corporation
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Arabin GmbH & Co. KG
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. medesign I.C. GmbH
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. IndoSurgicals Private Limited.
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Desco Medical India
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Narang Medical Limited.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. Bray Group Limited.
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Digitimer Ltd
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Thomas Medical.
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us